Mohamed El-Gabalawy, MD
Psychiatry · Pasadena, CANPI 1407967631
Payments from drug & device makers
What this record shows
Neurocrine Biosciences, Inc. accounts for 83.2% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $2,794, more than ten times the $271 reported in 2019.
Across 30 payments — averaging $111.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$3K
- Johnson & Johnson$428
- Teva Pharmaceuticals USA, Inc.$122
- Alkermes, Inc.$14
Across 193 payments — averaging $9695.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$704K
- E.r. Squibb & Sons, L.L.C.$466K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$261K
- AbbVie$247K
- Boehringer Ingelheim$178K
- Neurocrine Biosciences, Inc.$8K
- plus $7K from 1 others
What the payments were for
- Travel & lodging$1,93258%
- Food & beverage$1,42642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 22 | $2,794 |
| Johnson & Johnson | 6 | $428 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Alkermes, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$366
How this compares
$3,358 in reported general payments places this provider in the 85th percentile of 4,954 psychiatry providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Pasadena
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.